Related Experiment Video
Updated: Jul 26, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series
Ilaria Testi1,2, Camilo Brandão-de-Resende3,4, Alejandra De-La-Torre5
1Department of Uveitis, Moorfields Eye Hospital, NHS Foundation Trust, London, UK.
Insights
Ocular inflammatory events, such as uveitis, can occur in children after COVID-19 vaccination. Most cases resolved successfully with treatment, showing good visual outcomes in pediatric patients.
Area of Science:
- Ophthalmology
- Pediatrics
- Vaccinology
Background:
- Ocular inflammatory events have been documented in adults post-COVID-19 vaccination.
- This study investigates similar events in the pediatric population.
Purpose of the Study:
- To describe the characteristics and outcomes of ocular inflammatory events in individuals under 18 following COVID-19 vaccination.
Main Methods:
- A multinational case series was conducted.
- Included patients under 18 diagnosed with ocular inflammatory events within 28 days of COVID-19 vaccination.
Main Results:
- Twenty pediatric patients were included. Anterior uveitis was most common (40%), followed by intermediate uveitis (35%).
- Most events occurred within the first week post-vaccination (55%). Patients received topical/oral corticosteroids or increased immunosuppression.
- Sixty-five percent of patients achieved complete resolution without complications; all had preserved visual acuity.
Conclusions:
- COVID-19 vaccination may be associated with ocular inflammatory events in children.
- These events are generally treatable, with most pediatric patients experiencing favorable visual outcomes.
Background:
Ocular inflammatory events following COVID-19 vaccination have been reported in the adult population.
Methods:
Multinational case series of patients under the age of 18 diagnosed with ocular inflammatory events within 28 days of COVID-19 vaccination.
Results:
Twenty individuals were included. The most common event was anterior uveitis (n = 8, 40.0%), followed by intermediate uveitis (7 patients, 35%), panuveitis (4 patients, 20%), and posterior uveitis (1 patient, 5%). The event was noticed in the first week after vaccination in 11 patients (55.0%). Twelve patients (60.0%) had a previous history of intraocular inflammatory event. Patients were managed with topical corticosteroids (n = 19, 95.0%), oral corticosteroids (n = 10, 50.0%), or increased dose of immunosuppressive treatment (n = 6, 30.0%). Thirteen patients (65.0%) had a complete resolution of the ocular event without complications. All patients had a final visual acuity unaffected or less than three lines of loss.
Conclusion:
Ocular inflammatory events may happen in the paediatric population following COVID-19 vaccination. Most events were successfully treated, and all showed a good visual outcome.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Vaccinations
Photoreceptors and Visual Pathways

